CorVel (NASDAQ:CRVL) Stock Rating Upgraded by Wall Street Zen

by · The Cerbat Gem

CorVel (NASDAQ:CRVL – Get Free Report) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Sunday.

Separately, Weiss Ratings reiterated a “hold (c+)” rating on shares of CorVel in a report on Saturday, September 27th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, CorVel currently has an average rating of “Hold”.

Get Our Latest Analysis on CRVL

CorVel Price Performance

CRVL opened at $71.41 on Friday. The stock has a market cap of $3.66 billion, a P/E ratio of 36.81 and a beta of 0.95. The stock’s 50 day simple moving average is $83.65 and its 200 day simple moving average is $98.30. CorVel has a 1-year low of $71.20 and a 1-year high of $128.61.

CorVel (NASDAQ:CRVL – Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The business services provider reported $0.52 earnings per share for the quarter. The business had revenue of $234.71 million for the quarter. CorVel had a return on equity of 32.31% and a net margin of 10.98%.

Insiders Place Their Bets

In other CorVel news, CFO Brandon O’brien sold 1,764 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $91.54, for a total transaction of $161,476.56. Following the transaction, the chief financial officer owned 8,948 shares of the company’s stock, valued at $819,099.92. This represents a 16.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider Maxim Shishin sold 12,000 shares of the stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $89.16, for a total value of $1,069,920.00. Following the completion of the transaction, the insider directly owned 7,050 shares in the company, valued at $628,578. This trade represents a 62.99% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 44.56% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. Meeder Asset Management Inc. purchased a new position in shares of CorVel in the 1st quarter worth $25,000. von Borstel & Associates Inc. purchased a new position in shares of CorVel in the 1st quarter worth $28,000. Hantz Financial Services Inc. purchased a new position in shares of CorVel in the 2nd quarter worth $32,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new position in shares of CorVel in the 2nd quarter worth $37,000. Finally, Blue Trust Inc. raised its position in shares of CorVel by 235.4% in the 2nd quarter. Blue Trust Inc. now owns 550 shares of the business services provider’s stock worth $57,000 after buying an additional 386 shares during the period. 51.36% of the stock is owned by hedge funds and other institutional investors.

CorVel Company Profile

(Get Free Report)

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.

Recommended Stories